Abstract
Background Autism and autistic traits have been associated with greater risk of childhood trauma and adulthood psychopathology. However, the role that childhood trauma plays in the association between autism, autistic traits and depression in adulthood is poorly understood.
Methods We used a UK-based birth cohort with phenotype and genotype data on autism, autistic traits, childhood trauma and depression in up to 9,659 individuals prospectively followed up from birth until age 28 years. Using mixed-effects growth-curve models, we assessed trajectories of depression symptoms over time according to the presence or absence of autism/ autistic traits and explored whether these differed by trauma exposure. We further investigated the association between autism/ autistic traits and depression in adulthood using confounder-adjusted logistic regression models and undertook mediation analyses to investigate the relationship with childhood trauma.
Results All autism variables demonstrated increased depressive symptom trajectories between ages 10-28 years. Social communication difficulties (SCDs) were the most strongly associated with a depression diagnosis in adulthood (age 24 OR= 2.15; 95%CIs: 1.22-3.76). Trauma and autistic traits combined to further increase depression symptom scores. Mediation analyses provided evidence for direct pathways between autistic traits and increased risk of depression alongside indirect pathways through increased risk of trauma.
Conclusions Autism/ autistic traits increase the odds of experiencing childhood trauma and of being diagnosed with depression at age 18 and 24. Depressive symptom trajectories emergent in childhood persist into adulthood. The combined effect of SCDs and childhood trauma is greater than the individual exposures, suggesting worse depression symptomatology following trauma in individuals with SCDs.
Lay abstract Autism and autistic traits are linked to higher chances of experiencing traumatic events in childhood and having mental health problems as an adult. However, we don’t understand how childhood trauma influences the link between autistic traits and depression in adulthood.
Using data from a large birth cohort study in the UK, we tracked up to 9,659 people from birth until age 28 years. We looked at the links between autism, autistic traits, childhood trauma, and depression.
We found that all features related to autism were associated with more symptoms of depression between the ages of 10 and 28. Among these, difficulties in social communication were the most strongly connected to depression when they reached adulthood, more than doubling the risk.
We discovered that when childhood difficulties and autistic traits came together, the risk of experiencing depression symptoms increased even more. We showed that autistic traits raised the chances of depression both directly and indirectly, by increasing the chance of experiencing childhood trauma.
Taken together, our research shows that autism and autistic traits increase the likelihood of experiencing childhood trauma and being diagnosed with depression at ages 18 and 24. Signs of depression that appear in childhood tend to persist into adulthood. The combination of social communication difficulties and childhood trauma has a stronger impact on depression symptoms, indicating that people with these traits may experience more severe depression after facing traumatic events.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The UK Medical Research Council and the Wellcome Trust (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Jack F G Underwood and Paul Madley-Dowd will serve as guarantors for the contents of this paper. This research was funded in whole, or in part, by the Wellcome Trust [222849/Z/21/Z, 227063/Z/23/Z, and 204813/Z/16/Z]. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This study was supported by the National Institute for Health and Care Research Bristol Biomedical Research Centre at the University of Bristol and University Hospitals Bristol and the Weston NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. J.F.G.U. was supported by a Wellcome Trust GW4-CAT Clinical Doctoral Fellowship (222849/Z/21/Z), and this research was funded in part by the Wellcome Trust. DR and PMD acknowledge support via the NIH (1R01NS107607) and the Baily Thomas Charitable Fund. DR, PMD and CD are members of the UK Medical Research Council (MRC) Integrative Epidemiology unit, which is funded by the MRC (MC_UU_00032/02 and MC_UU_00032/6) and the University of Bristol. LH is supported by the Elizabeth Blackwell Institute (incorporating Wellcome Trust grant 204813/Z/16/Z), University of Bristol, and the Rosetrees Trust. ASFK is supported by a Wellcome Early Career Award (227063/Z/23/Z). A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). The funding organisations had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study (project B4018) was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees. Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All scripts used to create the data and run analyses are available from https://github.com/pmadleydowd/Autism-childhoodtrauma-depression. ALSPAC data cannot be shared publicly due to ethical agreements. Data is available on application to ALSPAC through their website: http://www.bristol.ac.uk/alspac.
